SCOTT RANDAL W.

PrivateCIK: 1337801
Location

LOS ALTOS, CA

SCOTT RANDAL W. sold 46.3% of their position (10K shares) of BRIDGEBIO PHARMA, INC. on the open market

Open‑market sale worth $671.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderSCOTT RANDAL W.CIK 1337801
IssuerBRIDGEBIO PHARMA, INC.CIK 1743881
Director
Since Jun 2020
-10K
Net shares
Net seller
$671.5K
Total sold
4
Open market trades
0B · 4S
6
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+10K

Price / share

$16.75

Trade value

$167.50K

% of position

86.3%
5/15/2026
11.59K21.59K

Common Stock

Direct
S · Sale

Shares

6.20K

Price / share

$66.69

Trade value

$413.46K

% of position

28.7%
5/15/2026
21.59K15.39K

Common Stock

Direct
S · Sale

Shares

2.09K

Price / share

$67.53

Trade value

$141K

% of position

13.6%
5/15/2026
15.39K13.30K

Common Stock

Direct
S · Sale

Shares

1.51K

Price / share

$68.23

Trade value

$103.16K

% of position

11.4%
5/15/2026
13.30K11.79K

Common Stock

Direct
S · Sale

Shares

200.00

Price / share

$69.12

Trade value

$13.82K

% of position

1.7%
5/15/2026
11.79K11.59K
Total

Net shares

+0.00

Net value

-$503.96K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

10K shares

Shares

10K

Strike price

16.75

Held after

21.50K

Exercisable

5/15/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned4K
Total
4K indirect4K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
SCOTT RANDAL W. — Insider Transaction (Form 4) Filed May 19, 2026 | Finecho